FDA Withdraws Approval of KV Pharmaceutical Co.'s Abbreviated Drug Applications

Summary

The Food and Drug Administration (FDA) is withdrawing approval of two abbreviated new drug applications (ANDA's) and one abbreviated antibiotic drug application (AADA) held by KV Pharmaceutical Co. due to the presence of untrue statements of material fact and insufficient evidence of effectiveness for the covered drugs.